• Responsible for global marketing of Women’s Health ultrasound business. Sales revenue 2008 totaling US$410 million, growth 20% compared to previous year, global market share 35%. • Developed & championed global strategic marketing (short thru long term) plan to build on existing expertise & expand into new markets • Lead team of Product & Clinical Managers (globally: USA & EU). Tasked with managing franchise growth strategy including developing product pipeline, product renovations & line extensions. Activities include: identifying & realizing new products – managing development process of new products from conception to global launch; business case development; brand strategy; forecasting overall market size & potential; pricing strategies; positioning & claims for new products; competitor insights; clinical validation; clinical trials & publication planning. Since joining GE: launched 2X new product & 8X product line extensions. Developed new Assisted Reproductive Medicine & Labor and Delivery market segments with product differentiator, marketing & sales tactics. • Lead global re-branding activities for Voluson: brand & product vision, messaging, and creative. • Introduced marketing tools to business, such as: Balanced Score Card, ROI, Promotional Review Board, Market Research best practices. • Supported corporate efforts in setting up process around clinical trial execution compliant with FDA / EMEA guidelines (ie. Good clinical practice standards / IRB process / informed consents physician & patients)

"US$24 billion Corporation made up of 6 businesses: HealthCare business develops, manufactures, markets &
sells medical devices. Annual revenue: US$17 billion."

• Responsible for oncology & dysphagia franchises of enteral clinical nutrition (ECN) business. Sales revenue 2005 totaling €35million. Growth compared to previous year: 50% in oncology & 29% in dysphagia. • Developed & championed global strategic marketing plan & sales forecast (2005-2010), for franchises. Worked together with local subsidiaries to incorporate global marketing plans into local marketing plans. Key global activities which impacted sales: – Brand line extension launches – market research, positioning & claims of products, campaign development, forecasting sales potential, supporting local subsidiaries with roll-out – Sales effectiveness: targeting high margin channels & co-promotion of products – Direct to consumer (DTC) marketing strategy & tactics such as Waiting room material, Internet promotion. Highest sales impact in non-reimbursed countries. – Built relationships with EU Medical & Patient associations to increase impact of education of clinical benefits of nutrition and to get our brands endorsed. – Developed & executed global/local KOL & MD strategy and tactics (Global advisory board, Speaker bureau, CME accredited programs, International congress symposia & presence) to create global & local band endorsement & to establish brand ambassadors. – Implemented internal promotion campaign aimed at reinforcing brand messaging; and establishing strong brand ambassadors within the company – Developed Reimbursement strategy to optimize reimbursement situation & pricing together with Medical & Regulatory. Healtheconomic dossier rolled-out in local markets & Clinical Trials initiated to support product positioning. • Together with colleagues from global marketing, developed (new) global marketing planning framework & process now used throughout ECN business. • New Product Development Lead: Cross-functional team of Research & Development, Regulatory, Manufacturing, Logistics, Medical, & Marketing. Key achievement: 6 new products developed in 2004 (1X oncology & 5X dysphagia); global launch of products in 2005). • Marketing Working-Group Lead: Team comprised of marketing, sales & medical reps. from local subsidiaries. Group focus: share best practices among countries; gain competitor insights; fine-tune marketing strategies. As lead, evaluated & approved/declined product launch business cases submitted by local subsidiaries.

"Numico Beheer BV manufacture and market infant food and specialized nutrition food products. The company is based in Schiphol, the Netherlands."

• US business unit exceeded sales revenue target and maintained market share. • Managed US$1.6 million promotional budget in 2002; US$3.5 million in 2003.  Led launch of Patient & Healthcare Professional Support Service (Avonex Alliance®) to Sales Force. Exceeded expected retention rates by 11% in competitive market. 25% increase in new patient starts enrolling in services. Together with Product Manager, developed Alliance® promotional materials across internet, collateral, live programs, and customer service channels. Analyzed sales data to evaluate success of service. • Owned Internet channel marketing activities: developed strategy, managed 3rd party partners. Grew membership database by 28%; 35% increase in site-visits over previous years. • Developed and promoted Refill Prescription data for AVONEX® and competitors in Physician sales materials. Sales Force rated this data as being most inpactful data source with customers in 2003. • Owned Nurse initiatives: developed strategy & executed tactics - National and Regional Nurse Faculty Boards, Accredited Educational Programs for MS Nurses, Promotional meetings for nurses. Positive impact on AVONEX sales & built endorsement for next generation MS product – Antegren® (Tysabri). • Contributed to strategy development for Phase 4 Patient Compliance Observational Study. • Led Customer Service (CS) cross-functional team to ensure marketing messages and projects were communicated to CS team for seamless execution of marketing’s activities. • Executed Mail Order Pharmacy and Nursing Partner compliance & persistency initiatives. • Provided input into development of 2004 AVONEX® marketing compliance & persistency plan.

"Third largest biotechnology company specialized in global commercialization of oncology and immunology
products; US$2.8 billion in sales."

• Responsible for positioning, promotion and sales of AVONEX® in territory. Exceeded sales goal by 10%. Successfully built strong relationships with key customers. • Developed sales targets and tactics for 2002. Analyzed territory market dynamics (SWOT analysis, market segmentation, positioning of product, competitive strategic assessment). • Organized Medical Education programs with targeted MDs – prescription rate of MDs increased by 20%. • Organized Accredited Medical Education programs for MS Nurses – impacting sales & improved patient compliance & persistency. • Organized & sponsored patient meetings together with local MS society.

"Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing."

• Set up and supported 24/7 Biogen-run AVONEX® Support Line: provided medical information, adverse event & product complaint reporting, and clinical support services. • Re-launched Patient & Healthcare Professional support service (AVONEX® MS Care Program) to Sales Force in BeNeLux, UK, and Ireland. Program increased patient retention rate by 50%. • Managed partnership with 3rd party Nursing Partners providing AVONEX® services. • Team lead for launch of AVONEX® line extension with Bioset in BeNeLux. 100% conversion in 60 days, 9% sales increase. (MBA project-marketing) • Contributed to strategy of Phase 4 Patient Quality of Life study, wrote protocol, selected CRO, negotiated contract, and oversaw study execution

"Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing."

• Worked together with business unit leads to develop 2001 five-year Long Range Plan for all International countries except North America. • Analyzed monthly International patient sales estimates for AVONEX® and its competitors.

"Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing,."

• Managed clinical research nursing department. Responsible for welfare and development of 30 full-time & 20 parttime staff, hiring of personnel, all operational aspects of clinical trial execution. • Reorganized department, redefined job responsibilities, empowered nursing staff to achieve measurable improvement in quality of study results, and increased effectiveness & efficiency of department. • Developed & implemented internal training program for Research Nurses. • Set-up Pharmacy department. Wrote Pharmacy Standard Operating Procedures. • Developed & executed ROI model for Nursing department’s involvement in executing clinical trials.

"Contract Research Organization specialized in phase I/II clinical research; $7 million revenue."

Executed phase 1 clinical trials. Responsible for quality of study and client satisfaction.

"Kendle is a leading global clinical research organization providing the full range of early– to late–stage clinical development services for the world's biopharmaceutical industry."

Emergency Nurse